<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-TRC-14005071</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2014-07-23</date_registration>
      <primary_sponsor>Taihe Hospital of Shiyan, Hubei Province</primary_sponsor>
      <public_title>Clinical research on subacute ischemic stroke therapy by umbilical cord blood stem cell</public_title>
      <acronym />
      <scientific_title>Clinical research on subacute ischemic stroke therapy by umbilical cord blood stem cell</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2014-08-01</date_enrolment>
      <type_enrolment />
      <target_size>Experience group:30;Control:30;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=4504</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>Other</phase>
      <hc_freetext>Ischemic cerebrovascular disease</hc_freetext>
      <i_freetext>Experience group:Stem cells;Control:Placebo + basal treatment;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Yunfu Wang</firstname>
        <middlename />
        <lastname />
        <address>Neurology department of Taihe Hospital, No. 32, South Renmin Road, Shiyan, Hubei Province</address>
        <city />
        <country1 />
        <zip>442000</zip>
        <telephone>+86 13971920566</telephone>
        <email>wyfymc@163.com</email>
        <affiliation>Taihe Hospital of Shiyan, Hubei Province</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yunfu Wang</firstname>
        <middlename />
        <lastname />
        <address>Neurology department of Taihe Hospital, No. 32, South Renmin Road, Shiyan, Hubei Province</address>
        <city />
        <country1 />
        <zip>442000</zip>
        <telephone>+86 13971920566</telephone>
        <email>wyfymc@163.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2 />
    </countries>
    <criteria>
      <inclusion_criteria>Among the age of 18~75 years old, gender not limited; Participants with cerebral infarction, the basal ganglia ischemic cerebrovascular disease onset time in two weeks and confirmed by MRI, NIHSS score of 4-12 points; Without serious heart, liver, kidney and the blood coagulation dysfunction; The informed consent signed by voluntary participants or their legal guardian subjects in accordance with the participants' willingness.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>75</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Have a history of serious drug allergy or allergic constitution; Have a serious cardiovascular, liver, kidney disease; With more severe respiratory, endocrine system diseases; With serious blood system diseases; With known or suspected malignant tumor; With difficult to control the infection; With a severe brain injury, resulting in severe neurological defects or psychiatric disease; Serum HIV antibody, syphilis antibody positive; Alcoholism and drug abusers; Pregnancy or may pregnancy and lactation women; Doctors think there are other reasons can not be included in the stem cell therapy.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>NIHSS;ADL;MRI;MRS;MRA;3D-ALS of brain;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>funds of science and technology research project, Hubei Province</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2014-01-20</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>